The role of epidemiology in the medical affairs function

How to identify and respond to the growing needs of medical affairs professionals

The role of medical affairs professionals is important, and as strategic leaders in the life sciences industry, these professionals are at the forefront of important topics such as clinical development and commercialization efforts as well as solving patient, payer, provider, and policymaker needs. Furthermore, there is an ever-increasing demand for research methodology expertise and strategy throughout this growing and evolving role/responsibility.

Join Baker Tilly for an informative webinar where our team will discuss important practical perspectives for medical affairs professionals to consider through an epidemiology lens. During the presentation, our team will discuss how core epidemiology skillsets become essential to medical affairs functions throughout the drug development cycle. We will also review relevant issues such as medical-legal-regulatory review, post-market study design, and real-world evidence (RWE) and health economics outcomes research (HEOR). Overarching themes including patient engagement, diversity and health equity will also be addressed as well.

Who should attend

• C-Suite professionals, presidents, vice presidents, management, medical affairs professionals and other leaders of life sciences organizations

Presenters

• Grace Macalino, PhD, MPH, Director, Baker Tilly
• Meg Glancey, MSPH, Manager, Baker Tilly
• Michael Ujhelyi, Pharm.D., FCCP, Medical Director, KARL STORZ

Learning objectives

• Understand the different components of the evolving medical affairs function
• Identify skillsets essential to medical affairs success
• Describe the epidemiology framework for medical affairs